These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 37731522)

  • 21. Association of Oral Anticoagulant Type With Risk of Dementia Among Patients With Nonvalvular Atrial Fibrillation.
    Chen N; Lutsey PL; MacLehose RF; Claxton JS; Norby FL; Chamberlain AM; Bengtson LGS; O'Neal WT; Chen LY; Alonso A
    J Am Heart Assoc; 2018 Nov; 7(21):e009561. PubMed ID: 30571385
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stroke prevention with direct oral anticoagulants in high-risk elderly atrial fibrillation patients at increased bleeding risk.
    Chao TF; Chan YH; Chiang CE; Tuan TC; Liao JN; Chen TJ; Lip GYH; Chen SA
    Eur Heart J Qual Care Clin Outcomes; 2022 Oct; 8(7):730-738. PubMed ID: 34694379
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Global Oral Anticoagulation Use Varies by Region in Patients With Recent Diagnosis of Atrial Fibrillation: The GLORIA-AF Phase III Registry.
    Bayer V; Kotalczyk A; Kea B; Teutsch C; Larsen P; Button D; Huisman MV; Lip GYH; Olshansky B
    J Am Heart Assoc; 2022 Mar; 11(6):e023907. PubMed ID: 35243870
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Direct Oral Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation: Patient-Level Network Meta-Analyses of Randomized Clinical Trials With Interaction Testing by Age and Sex.
    Carnicelli AP; Hong H; Connolly SJ; Eikelboom J; Giugliano RP; Morrow DA; Patel MR; Wallentin L; Alexander JH; Cecilia Bahit M; Benz AP; Bohula EA; Chao TF; Dyal L; Ezekowitz M; A A Fox K; Gencer B; Halperin JL; Hijazi Z; Hohnloser SH; Hua K; Hylek E; Toda Kato E; Kuder J; Lopes RD; Mahaffey KW; Oldgren J; Piccini JP; Ruff CT; Steffel J; Wojdyla D; Granger CB;
    Circulation; 2022 Jan; 145(4):242-255. PubMed ID: 34985309
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of outcomes of direct-acting oral anticoagulants vs. vitamin K antagonists in patients with bioprosthetic heart valves or valve repair: a systematic review and meta-analysis.
    Tang LL; Liang SW; Shi HL; Ye JJ
    Eur Rev Med Pharmacol Sci; 2021 Aug; 25(15):5006-5017. PubMed ID: 34355372
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and safety of direct oral anticoagulants (DOACs) versus vitamin K antagonist (VKA) among patients with atrial fibrillation and hypertrophic cardiomyopathy: a systematic review and meta-analysis.
    Rujirachun P; Charoenngam N; Wattanachayakul P; Winijkul A; Owattanapanich W; Ungprasert P
    Acta Cardiol; 2020 Dec; 75(8):724-731. PubMed ID: 31558097
    [No Abstract]   [Full Text] [Related]  

  • 27. Association of anticoagulant-related bleeding events with cancer detection in atrial fibrillation: A systematic review and meta-analysis.
    Papanastasiou A; Morsi-Yeroyannis A; Karagiannidis E; Kartas A; Doundoulakis I; Karvounis H; Giannakoulas G
    Hellenic J Cardiol; 2021; 62(5):359-365. PubMed ID: 33242617
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A comparison of the effects of NOAC and VKA therapy on the incidence of dementia in patients with atrial fibrillation: A systematic review and meta-analysis.
    Wang W; Fan W; Su Y; Hong K
    Clin Cardiol; 2023 Aug; 46(8):866-876. PubMed ID: 37366141
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effectiveness and Safety of Anticoagulation Therapy in Frail Patients With Atrial Fibrillation.
    Kim D; Yang PS; Sung JH; Jang E; Yu HT; Kim TH; Uhm JS; Kim JY; Pak HN; Lee MH; Lip GYH; Joung B
    Stroke; 2022 Jun; 53(6):1873-1882. PubMed ID: 35109686
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oral anticoagulants and risk of dementia: A systematic review and meta-analysis of observational studies and randomized controlled trials.
    Mongkhon P; Naser AY; Fanning L; Tse G; Lau WCY; Wong ICK; Kongkaew C
    Neurosci Biobehav Rev; 2019 Jan; 96():1-9. PubMed ID: 30391408
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy and Safety of Oral Anticoagulants for Atrial Fibrillation Patients With Chronic Kidney Disease: A Systematic Review and Meta-Analysis.
    Rhee TM; Lee SR; Choi EK; Oh S; Lip GYH
    Front Cardiovasc Med; 2022; 9():885548. PubMed ID: 35757349
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of the Efficacy and Safety of Non-vitamin K Antagonist Oral Anticoagulants with Warfarin in Atrial Fibrillation Patients with a History of Bleeding: A Systematic Review and Meta-Analysis.
    Suah BH; Lee ZY; Teo YH; Teo YN; Syn NLX; Soh RYH; Yeo LLL; Tan BYQ; Ho JS; Li TYW; Lee CH; Chan MY; Yeo TC; Wong RCC; Chai P; Sia CH
    Am J Cardiovasc Drugs; 2022 Sep; 22(5):511-521. PubMed ID: 35292921
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relationship of Anticoagulant Therapy With Cognitive Impairment Among Patients With Atrial Fibrillation: A Meta-Analysis and Systematic Review.
    Cheng W; Liu W; Li B; Li D
    J Cardiovasc Pharmacol; 2018 Jun; 71(6):380-387. PubMed ID: 29528873
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Direct oral anticoagulants versus warfarin in nonvalvular atrial fibrillation patients with prior gastrointestinal bleeding: a network meta-analysis of real-world data.
    Hu W; Cai H; Zhang J
    Eur J Clin Pharmacol; 2022 Jul; 78(7):1057-1067. PubMed ID: 35296907
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Catheter ablation and cognitive function in atrial fibrillation: A systematic review and meta-analysis.
    Chen P; Chen Z; Pan D; Miao L; Shi Y; Guo M; Du J
    Front Neurol; 2022; 13():934512. PubMed ID: 36158973
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oral anticoagulants for preventing stroke in patients with non-valvular atrial fibrillation and no previous history of stroke or transient ischemic attacks.
    Aguilar MI; Hart R
    Cochrane Database Syst Rev; 2005 Jul; 2005(3):CD001927. PubMed ID: 16034869
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Contemporary clinical and economic outcomes among oral anticoagulant treated and untreated elderly patients with atrial fibrillation: Insights from the United States Medicare database.
    Munir MB; Hlavacek P; Keshishian A; Guo JD; Mallampati R; Ferri M; Russ C; Emir B; Cato M; Yuce H; Hsu JC
    PLoS One; 2022; 17(2):e0263903. PubMed ID: 35176074
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of Oral Anticoagulant Therapy in Older Adults with Atrial Fibrillation After Acute Ischemic Stroke.
    McGrath ER; Go AS; Chang Y; Borowsky LH; Fang MC; Reynolds K; Singer DE
    J Am Geriatr Soc; 2017 Feb; 65(2):241-248. PubMed ID: 28039855
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Incidence of nonvalvular atrial fibrillation and oral anticoagulant prescribing in England, 2009 to 2019: A cohort study.
    Ajabnoor AM; Zghebi SS; Parisi R; Ashcroft DM; Rutter MK; Doran T; Carr MJ; Mamas MA; Kontopantelis E
    PLoS Med; 2022 Jun; 19(6):e1004003. PubMed ID: 35671329
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Uninterrupted anticoagulation during catheter ablation for atrial fibrillation: no difference in major bleeding and stroke between direct oral anticoagulants and vitamin K antagonists in an updated meta-analysis of randomised controlled trials.
    Brockmeyer M; Lin Y; Parco C; Karathanos A; Krieger T; Schulze V; Heinen Y; Bejinariu A; Müller P; Makimoto H; Kelm M; Wolff G
    Acta Cardiol; 2021 May; 76(3):288-295. PubMed ID: 32056498
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.